Search Results - "HINTERLEITNER, MARTINA"

Histologic Ex Vivo Validation of the [¹⁸F]SITATE Somatostatin Receptor PET Tracer.

Authors: Trautwein, Nils F. Mattern, Sven Hinterleitner, Martina et al.

Source: Journal of Nuclear Medicine. Aug2025, Vol. 66 Issue 8, p1204-1209. 6p.

Early Reconstitution of Antibody Secreting Cells after Allogeneic Stem Cell Transplantation.

Authors: Hinterleitner, Martina Hinterleitner, Clemens Malenke, Elke et al.

Source: Journal of Clinical Medicine. Jan2022, Vol. 11 Issue 1, p270. 1p.

Primary Renal Neuroendocrine Tumor: Diagnostic Challenges in a Rare Entity—A Case Report.

Authors: Lewetag, Raphaela D. Kluthe, Katharina Trautwein, Nils F. et al.

Source: Current Oncology. Feb2026, Vol. 31 Issue 2, p105. 8p.

Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine Malignancies.

Authors: Hinterleitner, Martina Sipos, Bence Wagner, Verena et al.

Source: Cancers. 5/15/2021, Vol. 13 Issue 10, p2286-2286. 1p.

Cardiac Metastases in Neuroendocrine Neoplasms: A Single-Center Experience of Clinical Characteristics and Outcomes.

Authors: Lewetag, Raphaela D. Trautwein, Nils F. Zdanyte, Monika et al.

Source: Cancers. Dec2025, Vol. 17 Issue 24, p3907. 16p.

One-day dual-tracer examination in neuroendocrine neoplasms: a real advantage of low activity LAFOV PET imaging.

Authors: Calderón, Eduardo Kiefer, Lena S. Schmidt, Fabian P. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2025, Vol. 52 Issue 7, p2463-2476. 14p.

Low-activity [¹⁸F]-somatostatin receptor (SSTR) imaging using [¹⁸F]SiTATE on a long axial field-of-view PET/CT scanner.

Authors: Trautwein, Nils F. Calderón, Eduardo Linder, Pia M. et al.

Source: EJNMMI Physics. 2/5/2025, Vol. 12 Issue 1, p1-15. 15p.

Myasthenia gravis as initial presentation of a pancreatic neuroendocrine tumor: A case report.

Authors: STINGU, ELENA DOBROWOLSKI, JEROME-MAURICE BOMBACH, PAULA et al.

Source: Experimental & Therapeutic Medicine. Nov2023, Vol. 26 Issue 5, p1-5. 5p.

Diagnostic Approaches for Neuroendocrine Neoplasms of Unknown Primary (NEN-UPs) and Their Prognostic Relevance—A Retrospective, Long-Term Single-Center Experience.

Authors: Schmidt, Moritz Hinterleitner, Clemens Singer, Stephan et al.

Source: Cancers. Sep2023, Vol. 15 Issue 17, p4316. 24p.

Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma Patients.

Authors: Schmidt, Moritz Benzler, Katrin Lauer, Ulrich M. et al.

Source: Journal of Clinical Medicine. Oct2022, Vol. 11 Issue 19, p5798. 14p.

Long‐term remission of small cell lung cancer after reactivation of tuberculosis following immune‐checkpoint blockade: A case report.

Authors: Sirgiovanni, Mattia Hinterleitner, Clemens Horger, Marius et al.

Source: Thoracic Cancer. Mar2021, Vol. 12 Issue 5, p699-702. 4p.

NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendothelioma.

Authors: Schmidt, Moritz Mattern, Sven Singer, Stephan et al.

Source: Journal of Cancer Research & Clinical Oncology. Aug2023, Vol. 149 Issue 9, p6753-6757. 5p.

Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation – development of a risk score.

Authors: Grottenthaler, Julia M. Konzelmann, Annette Stiegler, Anette et al.

Source: Transplant International. Nov2021, Vol. 34 Issue 11, p2257-2265. 9p.

Platelet-expressed immune checkpoint regulator GITRL in breast cancer.

Authors: Zhou, Yanjun Heitmann, Jonas S. Clar, Kim L. et al.

Source: Cancer Immunology, Immunotherapy. Sep2021, Vol. 70 Issue 9, p2483-2496. 14p.

Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment Options.

Authors: Bitzer, Michael Ostermann, Leonie Horger, Marius et al.

Source: JCO Precision Oncology. 3/30/2020, Vol. 4, p258-271. 14p.

Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?

Authors: Zhou, Yanjun Heitmann, Jonas S. Kropp, Korbinian N. et al.

Source: Diagnostics (2075-4418). Jul2021, Vol. 11 Issue 7, p1188. 1p.

Histologic Ex Vivo Validation of the [¹⁸F]SITATE Somatostatin Receptor PET Tracer.

Authors: Trautwein NF Mattern S Hinterleitner M et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Aug 01; Vol. 66 (8), pp. 1204-1209. Date of Electronic Publication: 2025 Aug 01.

Publication Type: Journal Article; Validation Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3.

Authors: Hinterleitner M Pfeiffer R Trautwein NF et al.

Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Jan 08; Vol. 14, pp. 1285529. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE

NUT Carcinoma-An Underdiagnosed Malignancy.

Authors: Lauer UM Hinterleitner M Horger M et al.

Source: Frontiers in oncology [Front Oncol] 2022 Jul 26; Vol. 12, pp. 914031. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression.

Authors: Rittig SM Lutz MS Clar KL et al.

Source: Frontiers in oncology [Front Oncol] 2022 Jul 08; Vol. 12, pp. 917834. Date of Electronic Publication: 2022 Jul 08 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE